Abstract

Weight loss triggers important metabolic responses to conserve energy, especially via the fall in leptin levels. Consequently, weight loss becomes increasingly difficult with weight regain commonly occurring in most dieters. Here we show that central growth hormone (GH) signaling also promotes neuroendocrine adaptations during food deprivation. GH activates agouti-related protein (AgRP) neurons and GH receptor (GHR) ablation in AgRP cells mitigates highly characteristic hypothalamic and metabolic adaptations induced by weight loss. Thus, the capacity of mice carrying an AgRP-specific GHR ablation to save energy during food deprivation is impaired, leading to increased fat loss. Additionally, administration of a clinically available GHR antagonist (pegvisomant) attenuates the fall of whole-body energy expenditure of food-deprived mice, similarly as seen by leptin treatment. Our findings indicate GH as a starvation signal that alerts the brain about energy deficiency, triggering key adaptive responses to conserve limited fuel stores.

Highlights

  • In the present study, we investigated the central effects of growth hormone (GH) on energy homeostasis as GH fulfills several requisites of an energy-deficiency signal to the brain

  • We found that the number agouti-related protein (AgRP) neurons positive for c-Fos was smaller in fasted AgRP GH receptor (GHR) KO mice as compared to fasted control mice, while the number of non-AgRP cells positive for c-Fos remained unchanged between the groups (Fig. 2a–c)

  • Clinical trials have indicated that leptin administration failed as an efficient therapeutical approach to treat obesity[24,25,26], it attenuates the neuroendocrine and metabolic changes induced by weight loss[1,2,3,4,5]

Read more

Summary

Introduction

We investigated the central effects of growth hormone (GH) on energy homeostasis as GH fulfills several requisites of an energy-deficiency signal to the brain. AgRP GHR KO mice displayed a similar body weight, food intake, energy expenditure, respiratory quotient, ambulatory activity, adiposity, lean body mass, body length, glucose tolerance and insulin sensitivity compared to control animals (Supplementary Fig. 3a-h and Supplementary Fig. 4a, b).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.